MedElevator Войти в исследования
← Поиск публикаций

DOI 10.21037/tcr-22-821

Медицинская библиотека · Translational cancer research · 2022

Is immunotherapy at reduced dose and radiotherapy for older patients with locally advanced non-small lung cancer feasible?-a narrative review by the international geriatric radiotherapy group.

Vinh-Hung Vincent, Gorobets Olena, Duerinkcx Andre, Dutta Suresh, Oboite Eromosele, Oboite Joan, Ali Ahmed, Mazibuko Thandeka, Karlsson Ulf, Chi Alexander, Lehrman David, Mohammed Omer Hashim, Mohammadianpanah Mohammad, Loganadane Gokoulakrichenane, Migliore Natalia, Vasileiou Maria, Nguyen Nam P, Giap Huan

СтатьяОбзорПеревод пока не подготовлен

Аннотация

BACKGROUND AND

OBJECTIVE

The standard of care for locally advanced non-small cell lung cancer (NSCLC) is either surgery followed by adjuvant chemotherapy with or without radiotherapy or concurrent chemotherapy and radiotherapy. However, older patients (70 years old or above) with multiple co-morbidities may not be able to tolerate the combined treatment due to its toxicity. Since lung cancer prevalence increases significantly with age, a new algorithm needs to be investigated to allow curative treatment for those with locally advanced disease.

METHODS

A literature search of the literature was conducted through PubMed and Google Scholar using search terms such as locally advanced NSCLC, older cancer patients, immunotherapy with check point inhibitors (CPI), and image-guided radiotherapy (IGRT). Abstracts were screened, full articles fitting the article topic were reviewed, and duplicated and non-English articles were excluded.

KEY CONTENT AND FINDINGS: Recently, CPI has been introduced and proven effective for selected patients with increased program death ligand 1 (PD-L1) expression (50% or above). A reduced dose for CPI (RDCPI) may be as effective as a full dose and may decrease treatment cost. New radiation technique such as IGRT may also minimize radiotherapy complication through normal lung and cardiac sparing.

CONCLUSIONS

IGRT and RDCPI may be an innovative option for older patients with locally advanced NSCLC and high PD-L1 expression and needs to be investigated in future prospective studies.

Для цитирования: Vinh-Hung Vincent, Gorobets Olena, Duerinkcx Andre, Dutta Suresh, Oboite Eromosele, Oboite Joan, Ali Ahmed, Mazibuko Thandeka, Karlsson Ulf, Chi Alexander, Lehrman David, Mohammed Omer Hashim, Mohammadianpanah Mohammad, Loganadane Gokoulakrichenane, Migliore Natalia, Vasileiou Maria, Nguyen Nam P, Giap Huan. Is immunotherapy at reduced dose and radiotherapy for older patients with locally advanced non-small lung cancer feasible?-a narrative review by the international geriatric radiotherapy group.. Translational cancer research. 2022. DOI: 10.21037/tcr-22-821.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.